Skip to main content
RecallFDAfda-F-1135-2024UNDECLARED ALLERGEN

PIES & SIDES CONNIE'S CARAMEL APPLE PIE 11 oz INGREDIENTS: APPLE PIE FILLING, SUGARS, VANILLA, CARAMEL EXTRACT BLEACHED FLOUR, SPICES, CO...

Category
Units Affected
2,984
Recall Date
March 26, 2024
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1135-2024.

During an inspection by NCDA, the firm was notified that the label does not list the sub ingredients for their products.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1135-2024.

Recall ongoing. Follow firm instructions.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Robeson Enterprises or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1135-2024.

Robeson Enterprises

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Robeson Enterprises Recall FAQ

Robeson Enterprises is the subject of a food safety report: PIES & SIDES CONNIE'S CARAMEL APPLE PIE 11 oz INGREDIENTS: APPLE PIE FILLING, SUGARS, VANILLA, CARAMEL EXTRACT BLEACHED FLOUR, SPICES, CO.... The notice was published on March 26, 2024 by the U.S. Food and Drug Administration (FDA). Approximately 2,984 units are potentially affected.